Showing results (221-230 of 493) with videos related to
Sort By:
Pageof 50
The Journal of Biological Chemistry|October 22, 2010
Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activityMartha Hale, George Oyler, Subramanyam Swaminathan, et al.Journal of Pharmaceutical Sciences|February 20, 2009
Extreme sensitivity of botulinum neurotoxin domains towards mild agitationStephen I Toth, Leonard A Smith, S Ashraf AhmedThe European Physical Journal. E, Soft Matter|April 4, 2017
Spontaneous imbibition in parallel layers of packed beadsS Ashraf, G Visavale, S S Bahga, et al.Plos Pathogens|September 27, 2008
Substrate binding mode and its implication on drug design for botulinum neurotoxin ADesigan Kumaran, Richa Rawat, S Ashraf Ahmed, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2018
Sarcoidosis-Like Reactions Induced by Checkpoint InhibitorsIoannis Gkiozos, Alexandra Kopitopoulou, Alexandros Kalkanis, et al.Electroencephalography and Clinical Neurophysiology|March 1, 1991
A comparison between electroencephalography and somatosensory evoked potentials for outcome prediction following severe head injuryD O Hutchinson, R W Frith, N A Shaw, et al.The American Journal of the Medical Sciences|February 1, 2013
Spinal cord neurosarcoidosisMimi Sohn, Daniel A Culver, Marc A Judson, et al.Diagnostics (Basel, Switzerland)|May 24, 2024
A Multichannel CT and Radiomics-Guided CNN-ViT (RadCT-CNNViT) Ensemble Network for Diagnosis of Pulmonary SarcoidosisJianwei Qiu, Jhimli Mitra, Soumya Ghose, et al.Chest|July 13, 2002
Thalidomide for chronic sarcoidosisRobert P Baughman, Marc A Judson, Alvin S Teirstein, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 30, 2025
WASOG Clinical Trial Endpoint Task Force: Executive SummaryRobert P Baughman, Elyse E Lower, Daniel A Culver, et al.Pageof 50